Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Pamela I Huanambal EsquénDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.ORCID 0000-0002-1488-827X
Diego A LeonardoDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.ORCID 0000-0003-4264-3074
Livia R ManzineDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.ORCID 0000-0002-2845-4958
Erick Suclupe FarroDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.
Jessica K KajfaszDepartment of Oral Biology, University of Florida College of Dentistry, Gainsville, FL 32610, USA.
Suelen S MelloDepartment of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0001-6389-6041
Mara C L NogueiraDepartamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto 15090-000, Brazil.
João Renato MunizDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.ORCID 0000-0003-2731-3966
Alessandro S NascimentoDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.ORCID 0000-0001-6656-5379
Michael S GilmoreDepartment of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.
Jacqueline AbranchesDepartment of Oral Biology, University of Florida College of Dentistry, Gainsville, FL 32610, USA.
José A LemosDepartment of Oral Biology, University of Florida College of Dentistry, Gainsville, FL 32610, USA.
Ilana L B C CamargoDepartment of Physics and Interdisciplinary Science, Sao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos 13563-120, Brazil.ORCID 0000-0003-4489-1215
Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/07600-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/23810-6National Council for Scientific and Technological Development 131384/2020-1National Council for Scientific and Technological Development 304325/2021-0National Council for Scientific and Technological Development 315847/2021-2
6 · The paper itself
Abstract
Daptomycin (DAP) is a therapeutic option for vancomycin-resistant
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Exploring Daptomycin Hypersensitivity in · full record | OpenQuestion